Gazyva/Gazyvaro (obinutuzumab) was found to significantly improve complete renal response in lupus nephritis patients, ...

Indeed, one of the criticisms of the widely used International Society of Nephrology and Renal Pathology Society (ISN/RPS) classification of lupus nephritis is the rather high interobserver ...

Background A 23-year-old white woman with a 3-year history of systemic lupus erythematosus and a 15-month history of lupus nephritis and retinal vasculitis was successfully treated with ...

Conventional lupus nephritis (LN) treatment based on cyclophosphamide, steroids and, recently, mycophenolatemofetil has improved the outcome of the disease over the last 50 years, although failure ...

Our Bureau, Bengaluru Friday, January 24, 2025, 14:30 Hrs [IST] ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...

Following his medical training in Pathology and Rheumatology at the National University of Singapore and ... and genetic players leading to murine lupus nephritis, with corresponding translational ...

Hyderabad: IIIT Hyderabad, in collaboration with Nizam's Institute of Medical Sciences (NIMS), has released digitised datasets of histopathological images focused on brain cancer and kidney disease ...

This initiative, known as the India Pathology Dataset (IPD), marks a significant step towards harnessing AI for improved clinical outcomes in brain cancer and kidney disease (lupus nephritis).

These datasets include high-resolution images of brain cancer and kidney disease (Lupus Nephritis), forming the cornerstone of the India Pathology Dataset (IPD) project. Histopathological images ...